Quality Assurance

Streamlined SOPs. Successful submissions.

At Notrox Quality Assurance (QA) team interacts directly with all process during the activities. Our quality and regulatory affairs specialists ensure adherence to these client requirements and any applicable regulations from the U.S. Food and Drug Administration (FDA), Canada’s Health Products and Food Branch Inspectorate, European Union, ANVISA and other international agencies during each phase of the clinical trial process. Our experience and oversight means that our clinical and bioanalytical services comply with Good Clinical Practices (GCP), Good Laboratory Practices (GLP) and International Conference on Harmonisation (ICH) GCP guidelines (E6). Quality is integrated into all of our processes.

As part of our commitment to continual improvement, we measure, assess and report quality data and seek ways to continually improve quality performance and results.

According to industry best practices, our corrective and preventive action (CAPA) process ensures we investigate significant out-of-specification events, deviations and discrepancies, report the findings and conclusions of the investigation and implement and document corrective actions. We maintain preventative maintenance and calibration programs, as applicable, to ensure operational equipment is appropriately maintained and operating as defined.

At the heart of every Notrox development program is an independent team of dedicated quality assurance (QA) specialists who ensure the credibility of your data. Our senior-level auditors conduct unbiased assessments of all aspects of a study, including auditing clinical and associated databases, vendors, validating software, and assuring the quality of individual reports, study files, tables, and listings. They can also provide training to prepare for actual regulatory inspections. Because of our entry to global footprint, at Notrox, we build quality into all our services.